Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7.
van Rossum PS, Goense L, van Hillegersberg R, Ruurda JP. van Rossum PS, et al. Among authors: goense l. Eur J Cancer. 2015 Sep;51(14):2095-6. doi: 10.1016/j.ejca.2015.05.029. Epub 2015 Jul 14. Eur J Cancer. 2015. PMID: 26187513 No abstract available.
Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis.
van Rossum PSN, Goense L, Meziani J, Reitsma JB, Siersema PD, Vleggaar FP, van Vulpen M, Meijer GJ, Ruurda JP, van Hillegersberg R. van Rossum PSN, et al. Among authors: goense l. Gastrointest Endosc. 2016 May;83(5):866-79. doi: 10.1016/j.gie.2015.11.026. Epub 2015 Nov 26. Gastrointest Endosc. 2016. PMID: 26632523 Review.
Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy.
Heethuis SE, van Rossum PS, Lips IM, Goense L, Voncken FE, Reerink O, van Hillegersberg R, Ruurda JP, Philippens ME, van Vulpen M, Meijer GJ, Lagendijk JJ, van Lier AL. Heethuis SE, et al. Among authors: goense l. Radiother Oncol. 2016 Jul;120(1):128-35. doi: 10.1016/j.radonc.2016.05.009. Epub 2016 Jun 10. Radiother Oncol. 2016. PMID: 27296409
Stage-directed individualized therapy in esophageal cancer.
Goense L, van Rossum PS, Kandioler D, Ruurda JP, Goh KL, Luyer MD, Krasna MJ, van Hillegersberg R. Goense L, et al. Ann N Y Acad Sci. 2016 Oct;1381(1):50-65. doi: 10.1111/nyas.13113. Epub 2016 Jul 6. Ann N Y Acad Sci. 2016. PMID: 27384385 Review.
Current treatment options for esophageal diseases.
Martínek J, Akiyama JI, Vacková Z, Furnari M, Savarino E, Weijs TJ, Valitova E, van der Horst S, Ruurda JP, Goense L, Triadafilopoulos G. Martínek J, et al. Among authors: goense l. Ann N Y Acad Sci. 2016 Oct;1381(1):139-151. doi: 10.1111/nyas.13146. Epub 2016 Jul 8. Ann N Y Acad Sci. 2016. PMID: 27391867 Review.
88 results